JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M511380200 on January 18, 2006

J. Biol. Chem., Vol. 281, Issue 11, 7421-7428, March 17, 2006
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
281/11/7421    most recent
M511380200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hamburgh, M. E.
Right arrow Articles by Prasad, V. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hamburgh, M. E.
Right arrow Articles by Prasad, V. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Structural Determinants of Slippage-mediated Mutations by Human Immunodeficiency Virus Type 1 Reverse Transcriptase*

Monica E. Hamburgh{ddagger}1, Kenneth A. Curr{ddagger}2, Melissa Monaghan{ddagger}3, Vasudev R. Rao{ddagger}, Snehlata Tripathi§, Bradley D. Preston, Stefan Sarafianos||, Eddy Arnold||, Thomas Darden**, and Vinayaka R. Prasad{ddagger}4

From the {ddagger}Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York 10461, the §Department of Biochemistry and Molecular Biology, University of Medicine and Dentistry of New Jersey, New Jersey Medical School, Newark, New Jersey 07103, the Department of Pathology, University of Washington, Seattle, Washington 98195, the ||Center for Advanced Biotechnology and Medicine (CABM) and Department of Chemistry and Chemical Biology, Rutgers University, Piscataway, New Jersey 08854, and the **Laboratory of Structural Biology, National Institutes of Health, NIEHS, Research Triangle Park, North Carolina 27707

Single-base deletions at nucleotide runs or -1 frameshifting by human immunodeficiency virus type 1 (HIV-1) reverse transcriptase (RT) result from template slippage during polymerization. In crystal structures of HIV-1 RT complexed with DNA-DNA template-primer, the palm subdomain in the template cleft contacts the template backbone near the proposed site of slippage via the Glu89 side chain. We investigated the role of Glu89 in frameshifting by perturbing this interaction. Substitutions with Asp, Gly, Ala, Val, Ser, Thr, Asn, or Lys were created in recombinant HIV RT, and frameshift frequencies of the resulting mutant RTs were measured. All substitutions led to reduced -1 frameshifting by HIV-1 RT (2-40-fold). Interestingly, the suppression of -1 frameshifting frequently coincided with an enhancement of +1 frameshifting (3-47-fold) suggesting that Glu89 can influence the slippage of both strands. Glu89 substitutions also led to reduced rates of dNTP misincorporation that paralleled reductions in -1 frameshifting, suggesting a common structural mechanism for both classes of RT error. Our results reveal a major influence of Glu89 on slippage-mediated errors and dNTP incorporation fidelity. The crystal structure of HIV-1 RT reveals a salt bridge between Glu89 and Lys154, which may facilitate -1 frameshifting; this concept is supported by the observed reduction in -1 frameshifting for K154A and K154R mutants.


Received for publication, October 19, 2005 , and in revised form, January 18, 2006.

* This work was supported in part by United States Public Health Service Grant AI30861 (to V. R. P.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by National Institutes of Health Institutional Training Grant NIGMS T32-GM07491. Data are from a thesis submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in the Sue Golding Graduate Division of Medical Sciences, Albert Einstein College of Medicine, Yeshiva University. Present address: Residency Program, Pediatrics, Rhode Island Hospital/Brown University, Providence, RI.

2 Present address: 1680 Owens St., Gladstone Institute of Virology and Immunology, San Francisco, CA 94158.

3 Present address: Center for Biotechnology at Stony Brook, Stony Brook, NY 11794.

4 To whom correspondence should be addressed: 1300 Morris Park Ave., Rm. GB 401, Bronx, NY 10461. Tel.: 718-430-2517; Fax: 718-430-8976; E-mail: prasad{at}aecom.yu.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Virol.Home page
L. Leppik, K. Gunst, M. Lehtinen, J. Dillner, K. Streker, and E.-M. de Villiers
In Vivo and In Vitro Intragenomic Rearrangement of TT Viruses
J. Virol., September 1, 2007; 81(17): 9346 - 9356.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2006 by the American Society for Biochemistry and Molecular Biology.